Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Integra Lifesciences Holdings Corp Investor Day (Virtual) Transcript

May 20, 2021 / 12:30PM GMT
Release Date Price: €57.5
Michael Beaulieu
Integra LifeSciences Holdings Corporation - Director of IR

Good morning, everyone. Welcome to Integra's 2021 Virtual Investor Day. I'm Mike Beaulieu, Director of Investor Relations, and we appreciate your interest in Integra and hope you're as excited as we are to be here this morning.

Earlier today, we issued a press release announcing that for the second quarter 2021 and the company now expects to achieve the higher end of both its revenue guidance range of $372 million to $378 million and its adjusted earnings per share range of $0.63 to $0.67. We also reaffirmed our full year 2021 revenue and adjusted earnings per share guidance. For your convenience, the slides for today's presentation are posted on our website at integralife.com in the Investor Relations section under Events & Presentations.

As a reminder, some of the comments we make today are forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company's Exchange Act reports filed with the SEC. Some of the numbers in today's presentation will contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot